The current guidelines recommend dual antiplatelet therapy (DAPT) with one potent P2Y12 inhibitor and aspirin for at least 12 months to reduce ischemic event rates in patients with acute myocardial infarction (AMI) [1,2]. Here, P2RY12 is linked to myocardial infarction.